The burden of cure: Long-term side effects following Hematopoietic Stem Cell Transplantation (HSCT) in children

Pediatric Clinics of North America

Volumn 57, Issue 1, 2010, Pages 323-342

  Baker, K Scott ^a   Bresters, Dorine ^b   Sande, Jane E ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Late effects; Long term follow up; Pediatric bone marrow transplantation

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; BUSULFAN; CALCIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOSCARNET; VITAMIN D;

ACUTE KIDNEY FAILURE; AZOOSPERMIA; BONE DEMINERALIZATION; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CATARACT; CHILDHOOD CANCER; CHILDHOOD MORTALITY; CHRONIC GRAFT VERSUS HOST DISEASE; DELAYED PUBERTY; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIGESTIVE SYSTEM INJURY; DOSE RESPONSE; DRUG MEGADOSE; FOLLOW UP; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS; HUMAN; HYPERTENSION; INFERTILITY; KIDNEY DYSFUNCTION; LIVER FOCAL NODULAR HYPERPLASIA; LUNG TOXICITY; METABOLIC SYNDROME X; MOUTH DISEASE; NEUROLOGICAL COMPLICATION; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; PREMATURE OVARIAN FAILURE; QUALITY OF LIFE; RADIATION DOSE; REVIEW; RISK ASSESSMENT; SECOND CANCER; SYSTEMIC DISEASE; THYROID DISEASE; VITAMIN SUPPLEMENTATION;

CHILD; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 77951102945     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2009.11.008     Document Type: Review

References (126)

1. Kremer L.C., van Dalen E.C., Offringa M., et al. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 2002, 13:503-512.
2. Kremer L.C., van der Pal H.J., Offringa M., et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 2002, 13:819-829.
3. Mertens A.C., Yasui Y., Neglia J.P., et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001, 19:3163-3172.
4. Baker K.S., Ness K.K., Steinberger J., et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 2007, 109:1765-1772.
5. Reusch J.E. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol 2002, 90:19G-26G.
6. Trevisan M., Liu J., Bahsaa F.B., et al. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998, 148:958-966.
7. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
8. Nuver J., Smit A.J., Postma A., et al. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 2002, 28:195-214.
9. Talvensaari K.K., Knip M. Childhood cancer and later development of the metabolic syndrome. Ann Med 1997, 29:353-355.
10. Talvensaari K.K., Lanning M., Tapanainen P., et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996, 81:3051-3055.
11. Taskinen M., Saarinen-Pihkala U.M., Hovi L., et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone marrow transplantation in childhood. Lancet 2000, 356:993-997.
12. Lorini R., Cortona L., Scaramuzza A., et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995, 15:873-877.
13. Majhail N.S., Challa T.R., Mulrooney D.A., et al. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hemtopoietic cell transplantation. Biol Blood Marrow Transplant 2009, 15(9):1100-1107.
14. Cerveri I., Zoia M.C., Flugoni P., et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999, 54(2):131-135.
15. Fanfulla F., Locatelli F., Zoia M.C., et al. Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J 1997, 10(10):2301-2306.
16. Frisk P., Arvidson J., Bratteby L.E., et al. Pulmonary function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 2004, 33(6):645-650.
17. Nysom K., Holm K., Hesse B., et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Arch Dis Child 1996, 74(5):432-436.
18. Savani B.N., Montero A., Srinivasan R., et al. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant 2006, 12(12):1261-1269.
19. Wieringa J., van Kralingen K.W., Sont J.K., et al. Pulmonary function impairment in children following hematopoietic stem cell transplantation. Pediatr Blood Cancer 2005, 45(3):318-323.
20. Hoffmeister P.A., Madtes D.K., Storer B.E., et al. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer 2006, 47(5):594-606.
21. Leneveu H., Bremont F., Rubie H., et al. Respiratory function in children undergoing bone marrow transplantation. Pediatr Pulmonol 1999, 28(1):31-38.
22. Bruno B., Souillet G., Bertrand Y., et al. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre. Bone Marrow Transplant 2004, 34(2):143-147.
23. Mertens A.C., Yasui Y., Liu Y., et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 2002, 95(11):2431-2441.
24. Berger C., Le-Gallop B., Donadieu J., et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2005, 35:991-995.
25. Cohen A., Bekassy A.N., Gaiero A., et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant 2008, 41:S43-S48.
26. Dahllof G., Hingorani S.R., Sanders J.E. Late effects following hematopoietic cell transplantation for children. Biol Blood Marrow Transplant 2008, 14:88-93.
27. Legault L., Bonny Y. Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 1999, 3:60-66.
28. Matsumoto M., Ishiguro H., Tomita Y., et al. Changes in thyroid function after bone marrow transplant in young patients. Pediatr Int 2004, 46:291-295.
29. Sanders J.E., Hoffmeister P.A., Woolfrey A.E., et al. Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. Blood 2009, 113:306-308.
30. Slatter M.A., Gennery A.R., Cheetham T.D., et al. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplant 2004, 33:949-953.
31. Sanders J.E., Pritchard S., Mahoney P., et al. Growth and development following marrow transplantation for leukemia. Blood 1986, 68(5):1129-1135.
32. Sanders J.E., Hawley J., Levy W., et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996, 87:3045-3052.
33. Clement-De Boers A., Oostdijk W., Van Weel-Sipman M.H., et al. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996, 129:544-550.
34. Sarafoglou K., Boulad F., Gillio A., et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997, 130:210-216.
35. Hovi L., Saarinen-Pihkala U.M., Taskinen M., et al. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GvHD and receiving glucocorticoid therapy. Bone Marrow Transplant 2004, 33:503-508.
36. Thibaud E., Rodriguez-Macias K., Trivin C., et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998, 21:287-290.
37. Hovi L., Tapanainen P., Saarinen-Pihkala U.M., et al. Impaired androgen production in female adolescents and young adults after total body irradiation prior to BMT in childhood. Bone Marrow Transplant 1997, 20:561-565.
38. Teinturier C., Hartmann O., Valteau-Couanet D., et al. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998, 22:989-994.
39. Anserini P., Chiodi S., Spinelli S., et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counseling. Bone Marrow Transplant 2002, 30:447-451.
40. Salooja N., Szydlo R.M., Socie G., et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001, 358:271-276.
41. Sanders J.E. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2008, 41:223-227.
42. Cohen A., Duell T., Socie G., et al. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT late-effects working party retrospective data. Bone Marrow Transplant 1999, 23:1043-1047.
43. Giorgiani G., Bozzola M., Locatelli F., et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant growth hormone. Blood 1995, 86(2):825-831.
44. Cohen A., Rovelli A., Bakker B., et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 1999, 93(12):4109-4115.
45. Sanders J.E., Guthrie K.A., Hoffmeister P.A., et al. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005, 105:1348-1354.
46. Chemaitilly W., Boulad F., Heller G., et al. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 2007, 40:29-35.
47. Nandagopal R., Laverdiere C., Mulrooney D., et al. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group. Horm Res 2008, 69:65-74.
48. Nysom K., Holm K., Michaaelsen K.F., et al. Bone mass after allogeneic BMT for childhood leukemia or lymphoma. Bone Marrow Transplant 2000, 25:191-196.
49. Kaste S.C., Shidler T.J., Tong X., et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004, 22:435-441.
50. Klopfenstein K.J., Clayton J., Rosselet R., et al. Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplant. Pediatr Blood Cancer 2009, 53:675-677.
51. Bhatia S., Ramsay N.K.C., Weisdorf D., et al. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998, 22:87-90.
52. Petryk A., Bergemann T.L., Polga K.M., et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006, 91:899-905.
53. Ferrone M., Geraci M. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Pract 2007, 22:329-339.
54. Carpenter P.A., Hoffmeister P., Chesnut C.H., et al. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007, 13:683-690.
55. Gronroos M.G., Bolme P., Winiarski J., et al. Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 2007, 39:717-723.
56. Kist-van Holthe J.E., Bresters D., Ahmed-Ousenkova Y.M., et al. Long-term renal function after hemopoietic stem cell transplantation. Bone Marrow Transplant 2005, 36:605-610.
57. Kist-van Holthe J.E., Goedvolk C.A., Brand R., et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002, 17:1032-1037.
58. Frisk P., Bratteby L.E., Carlson K., et al. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 2002, 29:129-136.
59. Patzer L., Ringelmann F., Kentouche K., et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 2001, 27:319-327.
60. Frisk P., Lonnerholm G., Oberg G. Disease of the liver following bone marrow transplantation in children: incidence, clinical course and outcome in a long-term perspective. Acta Paediatr 1998, 87(5):579-583.
61. Locasciulli A., Testa M., Valsecchi M.G., et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 1997, 90(9):3799-3805.
62. Tomas J.F., Pinilla I., Garcia-Buey M.L., et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000, 26(6):649-655.
63. Strasser S.I., Sullivan K.M., Myerson D., et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999, 93(10):3259-3266.
64. Bresters D., van Gils I.C.M., Dekker F.W., et al. Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: prevalence and risk factors. Bone Marrow Transplant 2008, 41(1):27-31.
65. Ivantes C.A., Amarante H., Ioshii S.O., et al. Hepatitis C virus in long-term bone marrow transplant survivors. Bone Marrow Transplant 2004, 33(12):1181-1185.
66. McKay P.J., Murphy J.A., Cameron S., et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996, 17(1):63-66.
67. Strasser S.I., Kowdley K.V., Sale G.E., et al. Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998, 22(2):167-173.
68. Bouyn C.I., Leclere J., Raimondo G., et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003, 97(12):3107-3113.
69. Sudour H., Mainard L., Baumann C., et al. Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplant 2009, 43(2):127-132.
70. Bagesund M., Viniarski J., Dahllof G. Subjective xerostomia in long-term surviving children and adolescents after pediatric bone marrow transplantation. Transplantation 2000, 69(5):822-826.
71. Dahllof G., Bagesund M., Ringden O. Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 1997, 20(6):479-483.
72. Holtta P., Hovi L., Saarinen-Pihkala U.M., et al. Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT. Cancer 2005, 103(7):1484-1493.
73. Holtta P., Alaluusua S., Saarinen-Pihkala U.M., et al. Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer 2005, 103(1):181-190.
74. Pajari U., Lanning M. Developmental defects of teeth in survivors of childhood ALL are related to the therapy and age at diagnosis. Med Pediatr Oncol 1995, 24(5):310-314.
75. Uderzo C., Fraschini D., Balduzzi A., et al. Long-term effects of bone marrow transplantation on dental status in children with leukaemia. Bone Marrow Transplant 1997, 20(10):865-869.
76. Vaughan M.D., Rowland C.C., Tong X., et al. Dental abnormalities after pediatric bone marrow transplantation. Bone Marrow Transplant 2005, 36(8):725-729.
77. Wogelius P., Dahllof G., Gorst-Rasmussen A., et al. A population-based observational study of dental caries among survivors of childhood cancer. Pediatr Blood Cancer 2008, 50(6):1221-1226.
78. Dahllof G. Craniofacial growth in children treated for malignant diseases. Acta Odontol Scand 1998, 56(6):378-382.
79. Curtis R.E., Rowlings P.A., Deeg H.J., et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997, 336(13):897-904.
80. Faraci M., Bekassy A.N., De Fazio V., et al. Non-endocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplant 2008, 41:S49-S57.
81. Ferry C., Gemayel G., Rocha V., et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007, 40:219-224.
82. Gurney J.G., Ness K.K., Rosenthal J., et al. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor Study. Cancer 2006, 106(6):1402-1408.
83. Leung W., Ahn H., Rose S.R., et al. A prospective cohort study of late sequelae of pediatric allogeneic hemtopoietic stem cell transplantation. Medicine 2007, 86(4):215-224.
84. Van Kempen-Harteveld M.L., Belkacemi Y., Kal H.B., et al. Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia. Int J Radiat Oncol Biol Phys 2002, 52(5):1367-1374.
85. Van Kempen-Harteveld M.L., Struikmans H., Kal H.B., et al. Cataract after total body irradiation and bone marrow transplantation: degree of visual impairment. Int J Radiat Oncol Biol Phys 2002, 52(5):1375-1380.
86. Kupst M.J., Penati B., Debban B., et al. Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study. Bone Marrow Transplant 2002, 30:609-617.
87. Phipps S., Rai S.N., Leung W.-H., et al. Cognitive and academic consequences of stem cell transplantation in children. J Clin Oncol 2008, 26:2027-2033.
88. Kramer J.H., Crittenden M.R., DeSantes K., et al. Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Bone Marrow Transplant 1997, 19:607-613.
89. Barrera M., Atenafu E., Andrews G.S., et al. Factors related to changes in cognitive, educational and visual motor integration in children who undergo hematopoietic stem cell transplant. J Pediatr Psychol 2008, 33(5):536-546.
90. Shah A.J., Epport K., Azen C., et al. Progressive decline in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol 2008, 30:411-418.
91. Szabolcs P., Niedzwiecki D. Immune reconstitution in children after unrelated transplantation. Cytotherapy 2007, 9(2):111-122.
92. Brown J., Boussiotis V.A. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008, 127(3):286-297.
93. Szabolcs P., Niedzwiecki D. Immune reconstitution in children after unrelated cord blood transplantation. Biol Blood Marrow Transplant 2008, 14(9):66-72.
94. Handgretinger R., Chen X., Pfeiffer M., et al. Cellular immune reconstitution after haploidentical transplantation in children. Biol Blood Marrow Transplant 2008, 14(1S1):59-65.
95. Eyrich M., Wollny G., Tzaribaschev N., et al. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biol Blood Marrow Transplant 2005, 11(3):194-205.
96. Fry T.J., Mackall C.L. Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future. Bone Marrow Transplant 2005, 35:S53-S57.
97. Lum L.G. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987, 69:369-380.
98. Peggs K.S. Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans. Cytotherapy 2006, 8:427-436.
99. Small T. Vaccination of children following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14(1 Suppl 1):54-58.
100. Carpenter P.A. Late effects of chronic graft-versus-host-disease. Best Pract Res Clin Haematol 2008, 21:309-331.
101. Perkins J.L., Kunin-Batson A.S., Youngren N.M., et al. Long-term follow-up of children who underwent hematopoietic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007, 49:958-963.
102. Leung W., Hudson M., Zhu Y., et al. Late effects in survivors of infant leukemia. Leukemia 2000, 14:1185-1190.
103. Odunusi E., Peters C., Krivit W., et al. Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention. J Pediatr Orthop 1999, 19(2):270-274.
104. Peters C., Shapiro E.G., Krivit W. Neuropsychological development in children with Hurler Syndrome following hematopoietic stem cell transplantation. Pediatr Transplant 1998, 2:250-253.
105. Cohen A., Rovelli A., Merlo D.F., et al. Risk for secondary thyroid carcinoma after hematopoietic stem cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 2007, 25(17):2449-2454.
106. Socie G., Curtis R.E., Deeg H.J., et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000, 18:348-357.
107. Kolb H.J., Socie G., Duell T., et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Ann Intern Med 1999, 131:738-744.
108. Baker K.S., DeFor T.E., Burns L.J., et al. New malignancies after blood or marrow stem cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003, 21(7):1352-1358.
109. Geenen M.M., Cardous-Ubbink M.C., Kremer L.C., et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007, 297(24):2705-2715.
110. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355(15):1572-1582.
111. Faraci M., Barra S., Cohen A., et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005, 63(5):1568-1575.
112. Leahey A.M., Teunissen H., Friedman D.L., et al. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 1999, 32(3):162-169.
113. Bresters D., van Gils I., Kollen W.J., et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2009, 5:4. DOI: 10.1038/bmt.2009.92.
114. Bhatia S., Francisco L., Carter A., et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007, 110(10):3784-3792.
115. Mertens A.C., Liu Q., Neglia J.P., et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008, 100(19):1368-1379.
116. Clarke S.A., Eiser C., Skinner R. Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature. Bone Marrow Transplant 2008, 42(2):73-82.
117. Löf C.M., Winiarski J., Giesecke A., et al. Health-related quality of life in adult survivors after paediatric allo-SCT. Bone Marrow Transplant 2009, 43(6):461-468.
118. Forinder U., Löf C., Winiarski J. Quality of life and health in children following allogeneic SCT. Bone Marrow Transplant 2005, 36(2):171-176.
119. Michel G., Bordigoni P., Simeoni M.C., et al. Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation. Bone Marrow Transplant 2007, 40(9):897-904.
120. Ortega J.J., Olive T., de Heredia C.D., et al. Secondary malignancies and quality of life after stem cell transplantation. Bone Marrow Transplant 2005, 35:S83-S87.
121. Helder D.I., Bakker B., de Heer P., et al. Quality of life in adults following bone marrow transplantation during childhood. Bone Marrow Transplant 2004, 33:329-336.
122. Ness K.K., Bhatia S., Baker K.S., et al. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the Bone Marrow Transplant Survivor Study. Arch Pediatr Adolesc Med 2005, 159:706-713.
123. Barrera M., Atenafu E. Cognitive, educational, psychosocial adjustment and quality of life of children who survive hematopoietic SCT and their siblings. Bone Marrow Transplant 2008, 42:15-21.
124. Barrera M., Atenafu E., Hancock K. Longitudinal health-related quality of life outcomes and related factors after pediatric SCT. Bone Marrow Transplant 2009, 44:249-256.
125. Rizzo J.D., Wingard J.R., Tichelli A., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006, 12(2):138-151.
126. Children's Oncology Group Survivorship Guidelines Available at:, Accessed September 15, 2009. http://www.survivorshipguidelines.org.